Allergan rep has questions ?????

Quote

Anonymous said:
Allergan may already have neuro reps trained on Botox, but heres what will likely happen:

Our great Actavis Leadership will make an appliance at your next National or POA Mtg. They will sit on the stage and tell you minimal cuts and everyone in the room has nothing to worry about.

Then a month before the alignment, they will drop the bomb that Legacy CNS and Derm will get Botox bc they already have so many neuro products and its just easier to train the existing force. but don't worry, they will promise to fill you guys in the vacant territories in those divisions.

I really feel for all you guys. These people are dirty, filthy and ruthless.
Click to expand...


Obviously you would know better than me and I'm sure you might be right but keep in mind the markets are totally different. A big part of the injector base in not just Neurology its PM&R and these guys do not rx ssri's or alzheimers meds.

I think Allergan's senior leadership in Neuro will make a VERY strong case about not changing too much in Neurosciences as we integrate.

Botox is a Billion dollar brand that grows at 17% per year dumping the existing commercial team and giving the new team a crash course along with 3 other drugs would be a horrendous decision. Botox is the crown jewel of this new organization and Allergan does a world class job in doing that. If anything our Neuro team should pick up Namenda to sell as a second position drug, while you guys focus on Phsycs.

I'm really not trying to be arrogant but you guys are simplifying what Botox is and how it's sold and just how important of a product it is for the combined company. I find it hard to believe they would change what has been working so dramatically, that would not be good for Saunders if he wants sales to grow, leave the Allergan Botox folks alone, they know what their doing and I'm sure that's been discussed already.

Keep in mind Irvine campus will remain open, if that's the case then the key commercial Allergan teams will probably remain intact and will be calling the shots.

Forest, Actavis were struggling companies with a lot of mediocre products, Allergan is not if they're smart and want their 66 Billion dollar investment to succeed don't mess with it too much.
 


Already secured an attorney...if you care about your career...get one as well. You can't tell a 12 time champion's club winner, "you don't meet expectations" and set them up for failure.
That is what Forest has done to legacy Actavis.
Good old boys club...
 


Anonymous said:
Do you have ANY clue about how to train a physician to use Botox in the OR or in-office for bladders?

Do you know anything about hospital P&T committees and the medical device approval process?

Do you know anything about in-servicing the OR staff on the equipment needed to inject Botox in the OR?

Do you know how to handle an appeals process when the physician in not paid correctly by Medicare?

Do you know how to speak with an Administrator who has not paid their Botox bill and is not longer able to purchase Botox for their upcoming in-office bladder cases?

Do you know anything about needles and why a certain needle is better for bladder injections?
Do you know anything about Specialty pharmacy shipments to physicians?

How about handling pharmacy managers who want to wait until the week of the case to order product?
Click to expand...

It is easy to ask these kind of questions in order to defend your current role with Allergan.
However you might want to remind yourself of a few things..
1. Majority of the people on CP are not the decision makers of how this deal gets rolled out and if you keep your job or not.
2. There was a time you didn't or couldn't answer any of the questions above and yet here you are...you learned.
3. You have no idea of the experience some Reps bring with this company. Sure there are entry level reps with no previous Pharma experience, there are also reps who do have buy and bill, hospital and device experience.
4. With the exception of WC, Actavis has tried very hard to keep successful and solid reps aligned with this company.

So before you go around making assumptions, condemning the current sales team and placing yourself on a pedestal, remember, we are ALL replaceable. Show a little humility because no one knows how everything will play out.
 


At your office building in Irvine it will say Actavis on the sign... Not Allergen. Some of your people will stay but most will go. Get over yourself.


Anonymous said:
Obviously you would know better than me and I'm sure you might be right but keep in mind the markets are totally different. A big part of the injector base in not just Neurology its PM&R and these guys do not rx ssri's or alzheimers meds.

I think Allergan's senior leadership in Neuro will make a VERY strong case about not changing too much in Neurosciences as we integrate.

Botox is a Billion dollar brand that grows at 17% per year dumping the existing commercial team and giving the new team a crash course along with 3 other drugs would be a horrendous decision. Botox is the crown jewel of this new organization and Allergan does a world class job in doing that. If anything our Neuro team should pick up Namenda to sell as a second position drug, while you guys focus on Phsycs.

I'm really not trying to be arrogant but you guys are simplifying what Botox is and how it's sold and just how important of a product it is for the combined company. I find it hard to believe they would change what has been working so dramatically, that would not be good for Saunders if he wants sales to grow, leave the Allergan Botox folks alone, they know what their doing and I'm sure that's been discussed already.

Keep in mind Irvine campus will remain open, if that's the case then the key commercial Allergan teams will probably remain intact and will be calling the shots.

Forest, Actavis were struggling companies with a lot of mediocre products, Allergan is not if they're smart and want their 66 Billion dollar investment to succeed don't mess with it too much.
Click to expand...
 


Anonymous said:
At your office building in Irvine it will say Actavis on the sign... Not Allergen. Some of your people will stay but most will go. Get over yourself.
Click to expand...

Guy, I'm trying to be nice.

The facts are Allergan is/was a much more successful company than Forest or Actavis ever were.

The future of the company will be growth from Allergan products.

Based on this there is a good chance a lot of Allergan people will stay

You need to get over yourself, you have no idea how this will shake out.
 








Anonymous said:
Company car type ? Forest fleet cars-- Equinox for Specialty Reps
Roommates at meetings ? Yes roommates
Leveling for experienced reps ?
Health Benefits ? Yes
401k matching amount?
Pension ? No
ESPP ? No

How many reps in each division -

Dermatology --reps have huge territories, not sure what the total number of reps are but theres room for more here.
Plastics ---none
Aesthetics ---none
Urology --- Our new CPU division. I believe its like 300 reps.
Eye Care ---none
Neuroscience CNS division pod set up

Thank you.
Click to expand...
[/QUOTE]

What is the bonus compensation range for each division?
 


Anonymous said:
Company car type ? Forest fleet cars-- Equinox for Specialty Reps
Roommates at meetings ? Yes roommates
Leveling for experienced reps ?
Health Benefits ? Yes
401k matching amount?
Pension ? No
ESPP ? No

How many reps in each division -

Dermatology --reps have huge territories, not sure what the total number of reps are but theres room for more here.
Plastics ---none
Aesthetics ---none
Urology --- Our new CPU division. I believe its like 300 reps.
Eye Care ---none
Neuroscience CNS division pod set up

Thank you.
Click to expand...
[/QUOTE]

the 401k 8% match each pay period? Allergan just changed their matching to Dec. 31. Very convenient since we won't be here after April 2015.
 
















Anonymous said:
I don't understand how they could do this.

Allergan has eye care, where Actavis has none

Allergan has med devices, in which Actavis has none

Allergan as aesthetics in which Acatavis has none

Botox is by far the biggest product of the combined entity especially in Neuro where it's on its way to be a billion dollar drug just for CNS/Rehab/Pain. It's a physician administered injectable procedure with a heavy reimbursement component, its not a 10th in class SSRI or an extended release version of a generic Rx drug (Namenda) There are no samples no real pod system. You just can't lump it in with 4 other me to products who's combined revenue's are not equal to the one in a pod system.

Outside of maybe eye care Allergan's sales forces bring in more money than Actavis's and are much more lean with fewer head count. If any model should be followed it should be Allergan's. Not saying that's what will happen but Allergan is true specialty while these clowns are not.

Uro is the only division in which Allergan reps will definitely have issues. Neuro possibly but Actavist's Neuro products are more physc based and not Nuero/Rehab/Pain.

Botox for all of it's indications in by FAR the best asset of the combined companies. If they were smart they would let the folks on both R&D and Commercial continue to do what they're doing within there respective business units and decide how Actavist and their products and reps fit in, not the other way around. Jerry Lynch should not decide how the Botox sales forces are deployed, the Allergan senior leadership should/need to be deciding that.
Click to expand...

Lets make Botox a second position detail in Neuros and First pos in plastic surgeons. How about Botox third position to GP's
 







Write your reply...
Top Bottom
Back
Quote